{"id":26698,"date":"2021-09-19T15:16:03","date_gmt":"2021-09-19T13:16:03","guid":{"rendered":"https:\/\/www.transgene.com\/?p=26698"},"modified":"2025-12-17T08:58:21","modified_gmt":"2025-12-17T07:58:21","slug":"john-felitti","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/john-felitti\/","title":{"rendered":"John FELITTI"},"content":{"rendered":"\n<p><img decoding=\"async\" class=\"imgMembers wp-image-18371 size-medium aligncenter\" src=\"..\/..\/wp-content\/uploads\/25-12-18-Transgene-0363-\u00a9-Bartosch-Salmanski.jpg\" alt=\"John FELITTI\"><\/p>\n<p>John Felitti occupe le poste de General Counsel &amp; Corporate Secretary chez Transgene depuis 2016. Auparavant, il a occup\u00e9 les fonctions d\u2019<em>Associate Vice President<\/em>, Droit des soci\u00e9t\u00e9s, Droit financier et boursier \u00e0 Sanofi apr\u00e8s avoir exerc\u00e9 d\u2019autres fonctions au sein des directions juridiques de Sanofi et d\u2019Aventis. De 1996 \u00e0 2003, il a exerc\u00e9 en tant qu\u2019avocat au bureau parisien du cabinet d\u2019avocats am\u00e9ricain Shearman &amp; Sterling. Il est admis au Barreau de New York et a pr\u00e9c\u00e9demment \u00e9t\u00e9 admis au Barreau de Paris.<\/p>\n<p>Apr\u00e8s avoir obtenu des dipl\u00f4mes en \u00e9conomie \u00e0 Harvard University (AB 1991) et au Coll\u00e8ge d\u2019Europe (DEA 1993), John Felitti a \u00e9tudi\u00e9 le droit \u00e0 l\u2019University of Michigan (JD 1996) et \u00e0 l\u2019Universit\u00e9 de Paris II \u2013 Panth\u00e9on (LLM 1997). Il est titulaire d\u2019un dipl\u00f4me en administration des affaires de l\u2019INSEAD (GEMBA 2015).<\/p>\n<div class=\"LienIn\"><a href=\"https:\/\/www.linkedin.com\/in\/johnfelitti\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-25981\" src=\"https:\/\/www.transgene.com\/wp-content\/uploads\/in.svg\" alt=\"\" width=\"30\" height=\"30\"><\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>John Felitti occupe le poste de General Counsel &amp; Corporate Secretary chez Transgene depuis 2016. Auparavant, il a occup\u00e9 les fonctions d\u2019Associate Vice President, Droit des soci\u00e9t\u00e9s, Droit financier et boursier \u00e0 Sanofi apr\u00e8s avoir exerc\u00e9 d\u2019autres fonctions au sein des directions juridiques de Sanofi et d\u2019Aventis. De 1996 \u00e0 2003, il a exerc\u00e9 en&hellip; <a class=\"more-link\" href=\"https:\/\/www.transgene.com\/fr\/john-felitti\/\">Poursuivre la lecture <span class=\"screen-reader-text\">John FELITTI<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[111],"tags":[],"class_list":["post-26698","post","type-post","status-publish","format-standard","hentry","category-outils-profils","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"John Felitti occupe le poste de General Counsel &amp; Corporate Secretary chez Transgene depuis 2016. Auparavant, il a occup\u00e9 les fonctions d\u2019Associate Vice President, Droit des soci\u00e9t\u00e9s, Droit financier et boursier \u00e0 Sanofi apr\u00e8s avoir exerc\u00e9 d\u2019autres fonctions au sein des directions juridiques de Sanofi et d\u2019Aventis. De 1996 \u00e0 2003, il a exerc\u00e9 en&hellip;\u2026","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/26698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=26698"}],"version-history":[{"count":7,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/26698\/revisions"}],"predecessor-version":[{"id":39546,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/26698\/revisions\/39546"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=26698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=26698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=26698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}